Noul Inc. has developed the next generation POC (Point-Of-Care) blood testing platform for resource-limited medical facilities, clinics, and local hospitals. Noul seeks to solve global challenges that threaten human life, to discover novel solutions, and to establish a new gold standard in POC blood testing. 

Noul’s solution aims to improve accessibility to proper health care by integrating innovations in biology, artificial intelligence, mobile technology, robotics, and software/hardware engineering. 

Noul has filed over 65 global patents, conducted more than seven field clinical trials, and has research partnerships with world-class global institutions.

[Mission]
We explore global challenges that threaten human health and life, discover novel potential solutions, and realize those possibilities.

[Goal]
1. To contribute to eliminating malaria, tb, aids and other neglected diseases through innovative diagnostic platform.
2. To proactively increase healthcare accessibility through next-generation blood diagnostics platform.


AI/ML

Biotechnology

Health Care

Health Diagnostics

Medical Devices

NOUL Co., Ltd.

David Lim

Youngmin Shin

YongJoon Kim

Simon Y. SHIN

Kyung-Hak Choi

Jungkwon Ahn

Jinwon Seo

DaeSeon Jeong

NOUL Co., Ltd.

Org chart

Similar companies